Introduction On behalf of National Falls Prevention Coordination Group, we were tasked with creating a user-friendly guide on Medicines and Falls. We delivered two sessions on this topic one at British Geriatric Society Conference in November 2022 and another to Specialist Pharmacy Service audience in January 2024. Method Audience participation was used in both sessions as part of the discussion on ‘What do you consider important when completing a medication review in a person who is at risk of falls?’ and ‘Which group of medicines do you prioritise for deprescribing discussion in patients at risk of falls?’. The results from slido contribution were analysed for trends and future learning needs. Results In the SPS audience, greater level of importance was imparted on individual drug classes when considering question of ‘what is important when reviewing a person at risk of falls’ with anticholinergic burden being quoted most frequently and patient goals being second. Reducing risk and patient goals were the two items which the BGS audience prioritised. In terms of groups of medication to prioritise for deprescribing discussion, SPS audience once again chose anticholinergic medication followed by sedatives while BGS categorised antihypertensives and diuretics most commonly. Conclusion(s) When completing falls medication reviews, medication groups were generally thought to be important by pharmacy-focused audience, with patient goals the second most important aspect whilst the BGS audience prioritised reducing risk and patient goals. There should be greater emphasis on managing risk as part of teaching offerings to teams where therapeutics is the core focus. In terms of groups of medications to deprescribe, better guidance around reviewing antihypertensives and diuretics would facilitate more effective falls medication reviews. The difference observed between prioritising anticholinergic burden reduction indicates that general geriatric audience would benefit from further awareness raising of their contribution to falls risk.

中文翻译：

---

2285 药物与跌倒——听众的参与对未来的学习需求有什么影响？


简介 我们代表国家跌倒预防协调小组，负责创建一份用户友好的药物和跌倒指南。我们就此主题举办了两场会议，一场是在 2022 年 11 月的英国老年医学会会议上，另一场是在 2024 年 1 月向专业药房服务观众举办的。方法 在两场会议中都使用了观众参与，作为“在为有跌倒风险的人完成药物审查时，您认为什么很重要”和“您优先考虑哪组药物来为有跌倒风险的患者开具处方的讨论”的一部分。对 slido 贡献的结果进行了趋势和未来学习需求分析。结果 在 SPS 受众中，在考虑“在审查有跌倒风险的人时什么重要”的问题时，单个药物类别被赋予了更高的重要性，其中抗胆碱能负担被引用得最频繁，患者目标被引用得次之。降低风险和患者目标是 BGS 受众优先考虑的两个项目。在取消处方讨论中优先考虑的药物组方面，SPS 观众再次选择抗胆碱能药物，其次是镇静剂，而 BGS 最常见的是抗高血压药和利尿剂。结论 在完成跌倒药物审查时，以药房为中心的受众通常认为药物组很重要，患者目标是第二重要的方面，而 BGS 受众优先考虑降低风险和患者目标。应该更加强调风险管理，作为向以治疗为核心重点的团队教授产品的一部分。 就要取消处方的药物组而言，围绕审查抗高血压药和利尿剂的更好指导将有助于更有效的跌倒药物审查。在优先考虑减轻抗胆碱能负担之间观察到的差异表明，普通老年病观众将受益于进一步提高对他们导致跌倒风险的影响的认识。